IMMY买入原因:今天IMMY发的干眼症药物为Restasis的仿制药,RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%,现有竞争对手仅有Shire’s idra,占20%的市场。IMMY的仿制药由于是走低价路线,有可...查看全文
TLS美股研究2017-04-09 21:31
回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88,也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注,眼科市场天花板逐渐打开,公司高管参与增发,市值迷你,会是小黑马吗 查看全文
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2015-05-20 AccNo: 0001493152-15-002169 Size: 57 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K/A [Amend] - Current report Filed: 2015-08-06 AccNo: 0001493152-15-003393 Size: 18 KBItem 8.01: Other Events 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2015-09-29 AccNo: 0001493152-15-004558 Size: 20 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2015-09-17 AccNo: 0001493152-15-004394 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2015-09-02 AccNo: 0001493152-15-004126 Size: 30 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2015-08-12 AccNo: 0001493152-15-003566 Size: 286 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits http:/...
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2015-08-05 AccNo: 0001493152-15-003375 Size: 147 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem...
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2015-07-16 AccNo: 0001493152-15-002993 Size: 21 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-08-12 AccNo: 0001493152-15-003565 Size: 5 MB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 美东时间 2015-08-12 16:30 After Market Close:IMPRIMIS PHARMA Earning Release . Wall St EPS Est ($):-0.33. 网页链接